Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
Launched by NOVARTIS VACCINES · Nov 18, 2013
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female aged 4 years to less than 18 years of age.
- • 2. Individual who had a parent or guardian who could give written informed consent after understanding the nature of the study and comply with study procedures and were available for follow-up.
- • 3. If the individual was of an age where, according to local regulations, informed assent is required, that individual had provided assent to participate in the study.
- Exclusion Criteria:
- • 1. Individuals recently vaccinated against influenza
- • 2. Subjects with contraindications to receive influenza vaccine
About Novartis Vaccines
Novartis Vaccines, a division of Novartis, is dedicated to the research, development, and commercialization of innovative vaccines aimed at preventing infectious diseases and addressing unmet medical needs globally. With a strong focus on scientific excellence and patient safety, Novartis Vaccines leverages advanced technologies and collaborative partnerships to enhance vaccine efficacy and accessibility. The division is committed to advancing public health through rigorous clinical trials and is driven by a mission to protect lives and improve health outcomes worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Cleveland, Ohio, United States
Metairie, Louisiana, United States
Mobile, Alabama, United States
Lexington, Kentucky, United States
San Antonio, Texas, United States
Denver, Colorado, United States
Sacramento, California, United States
Austin, Texas, United States
Salt Lake City, Utah, United States
Cincinnati, Ohio, United States
Oklahoma City, Oklahoma, United States
Louisville, Kentucky, United States
Omaha, Nebraska, United States
San Diego, California, United States
Las Vegas, Nevada, United States
Dallas, Texas, United States
Metairie, Louisiana, United States
San Francisco, California, United States
Mesa, Arizona, United States
Santa Rosa, California, United States
Binghamton, New York, United States
Charlottesville, Virginia, United States
Modesto, California, United States
Marietta, Georgia, United States
St. Louis, Missouri, United States
Wilmington, North Carolina, United States
Charleston, South Carolina, United States
Jonesboro, Arkansas, United States
Nashville, Tennessee, United States
Oklahoma City, Oklahoma, United States
Kansas City, Missouri, United States
Round Rock, Texas, United States
Kansas City, Missouri, United States
Anaheim, California, United States
San Diego, California, United States
San Antonio, Texas, United States
Colorado Springs, Colorado, United States
Council Bluffs, Iowa, United States
Hermitage, Pennsylvania, United States
Omaha, Nebraska, United States
Fort Worth, Texas, United States
San Angelo, Texas, United States
Peoria, Illinois, United States
Bristol, Tennessee, United States
Mt. Pleasant, South Carolina, United States
Paramount, California, United States
Newton, Kansas, United States
Wichita, Kansas, United States
Louisville, Kentucky, United States
Binghamton, New York, United States
Anderson, South Carolina, United States
Kettering, Ohio, United States
West Jordan, Utah, United States
Marietta, Georgia, United States
South Jordan, Utah, United States
Sellersville, Pennsylvania, United States
Salt Lake City, Utah, United States
Denver, Colorado, United States
San Francisco, California, United States
Cincinnati, Ohio, United States
Layton, Utah, United States
Pinellas Park, Florida, United States
West Jordan, Utah, United States
Woodstock, Georgia, United States
Tulsa, Oklahoma, United States
Huntsville, Alabama, United States
Downey, California, United States
Erie, Pennsylvania, United States
Upper St. Clair, Pennsylvania, United States
Jefferson City, Tennessee, United States
Chandler, Arizona, United States
Thornton, Colorado, United States
Lake Mary, Florida, United States
Dayton, Ohio, United States
Melbourne, Florida, United States
Las Vegas, Nevada, United States
Burke, Virginia, United States
Lebanon, Tennessee, United States
Fremont, Nebraska, United States
West Covina, California, United States
Draper, Utah, United States
Atlanta, Georgia, United States
Boise, Idaho, United States
Garden Grove, California, United States
Miami Beach, Florida, United States
Akron, Ohio, United States
Boca Raton, Florida, United States
Bellevue, Nebraska, United States
Draper, Utah, United States
Mishawaka, Indiana, United States
Jefferson City, Tennessee, United States
Harrisburg, Arkansas, United States
Opa Locka, Florida, United States
Patients applied
Trial Officials
Novartis Vaccines
Study Chair
Novartis Vaccines
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials